Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful.
Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.
This report contains market size and forecasts of Viscosupplementation Injection in global, including the following market information:
Global Viscosupplementation Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Viscosupplementation Injection Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Viscosupplementation Injection companies in 2021 (%)
The global Viscosupplementation Injection market was valued at 1173.2 million in 2021 and is projected to reach US$ 1701.5 million by 2028, at a CAGR of 5.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Single Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Viscosupplementation Injection include Sanofi, Anika Therapeutics, Seikagaku, Zimmer Biomet, Bioventus, Ferring, LG Chem, Freda and Haohai Biological and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Viscosupplementation Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viscosupplementation Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Viscosupplementation Injection Market Segment Percentages, by Type, 2021 (%)
Single Injection
Three Injection
Five Injection
Global Viscosupplementation Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Viscosupplementation Injection Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Viscosupplementation Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Viscosupplementation Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Viscosupplementation Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Viscosupplementation Injection revenues share in global market, 2021 (%)
Key companies Viscosupplementation Injection sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Viscosupplementation Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng

LEAVE A REPLY

Please enter your comment!
Please enter your name here